{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:58:14Z","timestamp":1792058294873,"version":"4.4.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,31]],"date-time":"2016-12-31T00:00:00Z","timestamp":1483142400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.nrl.2014.12.008","type":"journal-article","created":{"date-parts":[[2015,2,7]],"date-time":"2015-02-07T22:07:51Z","timestamp":1423346871000},"page":"69-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Epilepsia miocl\u00f3nica en el s\u00edndrome de Down y en la enfermedad de Alzheimer"],"prefix":"10.1016","volume":"32","author":[{"given":"J.S.","family":"Aller-Alvarez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Men\u00e9ndez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Ribacoba-Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Salvado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Su\u00e1rez-Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sueiras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Toledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Salas-Puig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"\u00c1lvarez-Sabin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrl.2014.12.008_bib0095","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1212\/WNL.36.9.1226","article-title":"Seizures and myoclonus in patients with Alzheimer's disease","volume":"36","author":"Hauser","year":"1986","journal-title":"Neurology."},{"key":"10.1016\/j.nrl.2014.12.008_bib0100","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.braindev.2004.07.008","article-title":"Down syndrome, Alzheimer's disease and seizures","volume":"27","author":"Menendez","year":"2005","journal-title":"Brain Dev."},{"key":"10.1016\/j.nrl.2014.12.008_bib0105","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1001\/archneur.1990.00530030029011","article-title":"The natural history of dementia in Down's syndrome","volume":"47","author":"Evenhuis","year":"1990","journal-title":"Arch Neurol."},{"key":"10.1016\/j.nrl.2014.12.008_bib0110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000093664","article-title":"Prevalence and causes of seizures at the time of diagnosis of probable Alzheimer's disease","volume":"22","author":"Lozsadi","year":"2006","journal-title":"Dement Geriatr Cogn Disord."},{"key":"10.1016\/j.nrl.2014.12.008_bib0115","first-page":"5","article-title":"Epilepsie myoclonique s\u00e9nile? Myoclonies d\u2019apparition tardive dans le syndrome de Down","volume":"1","author":"Genton","year":"1994","journal-title":"Epilepsies."},{"key":"10.1016\/j.nrl.2014.12.008_bib0120","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.seizure.2010.04.008","article-title":"Senile myoclonic epilepsy: Delineation of a common condition associated with Alzheimer's disease in Down syndrome","volume":"19","author":"De Simone","year":"2010","journal-title":"Seizure."},{"key":"10.1016\/j.nrl.2014.12.008_bib0125","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1684\/epd.2011.0426","article-title":"Epilepsy in adult patients with Down syndrome: A clinical-video EEG study","volume":"13","author":"Vignoli","year":"2011","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.nrl.2014.12.008_bib0130","doi-asserted-by":"crossref","first-page":"E2895","DOI":"10.1073\/pnas.1121081109","article-title":"Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model","volume":"42","author":"Sanchez","year":"2012","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.nrl.2014.12.008_bib0135","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1212\/WNL.0b013e318230a16c","article-title":"Chronic divalproex sodium use and brain atrophy in Alzheimer disease","volume":"13","author":"Fleisher","year":"2011","journal-title":"Neurology."},{"key":"10.1016\/j.nrl.2014.12.008_bib0140","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/archgenpsychiatry.2011.72","article-title":"Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease","volume":"8","author":"Tariot","year":"2011","journal-title":"Arch Gen Psychiatry."},{"key":"10.1016\/j.nrl.2014.12.008_bib0145","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/jamaneurol.2013.136","article-title":"Seizures and epileptiform activity in the early stages of Alzheimer disease","volume":"70","author":"Vossel","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nrl.2014.12.008_bib0150","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Towards de\ufb01ning the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging \u2014Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nrl.2014.12.008_bib0155","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nrl.2014.12.008_bib0160","first-page":"613","article-title":"Implications for treatment: GABAA receptors in aging, Down syndrome and Alzheimer's disease","volume":"117","author":"Rissman","year":"2011","journal-title":"J Neurochem."},{"key":"10.1016\/j.nrl.2014.12.008_bib0165","doi-asserted-by":"crossref","first-page":"178","DOI":"10.5698\/1535-7511-12.5.178","article-title":"Untangling Alzheimer's disease and epilepsy","volume":"12","author":"Scharfman","year":"2012","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.nrl.2014.12.008_bib0170","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0306-4522(00)00163-9","article-title":"Density and pharmacology of alpha5 subunit-containing GABA(A) receptors are preserved in hippocampus of Alzheimer's disease patients","volume":"98","author":"Howell","year":"2000","journal-title":"Neuroscience."},{"key":"10.1016\/j.nrl.2014.12.008_bib0175","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1523\/JNEUROSCI.4152-10.2011","article-title":"Amyloid-\u03b2\/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease","volume":"31","author":"Roberson","year":"2011","journal-title":"J Neurosci."},{"key":"10.1016\/j.nrl.2014.12.008_bib0180","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s10072-011-0714-1","article-title":"Atypical presentation of a novel Presenilin 1 R377W mutation: Sporadic, late-onset Alzheimer disease with epilepsy and frontotemporal atrophy","volume":"33","author":"Borroni","year":"2012","journal-title":"Neurol Sci."}],"container-title":["Neurolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485315000031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485315000031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T19:39:26Z","timestamp":1598729966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213485315000031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0213485315000031"],"URL":"https:\/\/doi.org\/10.1016\/j.nrl.2014.12.008","relation":{},"ISSN":["0213-4853"],"issn-type":[{"value":"0213-4853","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epilepsia miocl\u00f3nica en el s\u00edndrome de Down y en la enfermedad de Alzheimer","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrl.2014.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}